Abstract
Oligoribonucleotides carrying 5-ethyluridine units were prepared using solid-phase phosphoramidite chemistry. The introduction of the tert-butyldimethylsilyl group at the 2′-OH position proceeded in good yield and very high 2′-regioselectivity. RNA duplexes carrying 5-ethyluridine either at the sense or the guide strands display RNAi activity comparable to or slightly better than that of unmodified RNA duplexes. Gene suppression experiments using luciferase targets in SH-SY5Y cells show that the ethyl group is generally well accepted at all positions although a small decrease in RNA interference activity is observed when one 5-ethylU residue is incorporated in the 3′ overhangs.
Similar content being viewed by others
Abbreviations
- as:
-
Guide (antisense) strand
- ACN:
-
Acetonitrile
- DIPEA:
-
N,N-diisopropylethylamine
- DMAP:
-
N,N-dimethylaminopyridine
- DMEM:
-
Dulbecco’s modified Eagle medium
- DMT:
-
4,4′-Dimethoxytrityl
- EtOAc:
-
Ethyl acetate
- FBS:
-
Fetal bovine serum
- HEPES:
-
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
- MeOH:
-
Methanol
- siRNA:
-
Small interfering RNA
- ss:
-
Sense strand
- TBAF:
-
Tetrabutylammonium fluoride
- TBDMS:
-
tert-Butyldimethylsilyl
- TEAA:
-
Triethylammonium acetate
References
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806–811. doi:10.1038/35888
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498. doi:10.1038/35078107
Behlke MA (2008) Chemical modification of siRNA for in vivo use. Oligonucleotides 18: 305–320. doi:10.1089/oli.2008.0164
Watts JK, Deleavey GF, Damha MJ (2008) Chemically modified siRNA: tools and applications. Drug Discov Today 13: 842–855. doi:10.1016/j.drudis.2008.05.007
Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago-2 containing RNAi enzyme complexes. Cell 123: 607–620. doi:10.1016/j.cell.2005.08.044
Bramsen JB, Laursen MB, Nielsen AF, Hansen TB, Bus C, Lankjaer N, Babu BR, Hojland T, Abramov M, van Aerschot A, Odadzic D, Smicius R, Haas J, Andree C, Barman J, Wenska M, Srivastava P, Zhou C, Honcharenko D, Hess S, Múller E, Bobkov GV, Mikhailov SN, Fava E, Meyer TF, Chatopadhyaya J, Zerial M, Engels JW, Herdewijn P, Wengel J, Kjems J. (2009) A large-scale chemical modification screen identifies design rules to generate siRNAs with high stability and low toxicity. Nucleic Acids Res 37: 2867–2881. doi:10.1093/nar/gkp106
de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6: 443–453. doi:10.1038/nrd2310
de Martimprey H, Vauthier C, Malvy C, Couvreur P (2009) Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. Eur J Pharm Biopharm 71: 490–504. doi:10.1016/j.ejpb.2008.09.024
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Röhl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manoharan M, Vornlocher HP (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173–178. doi:10.1038/nature03121
Said Hassane F, Saleh AF, Abes R, Gait MJ, Lebleu B (2010) Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci 67:715–726. doi:10.1007/s00018-009-0186-0
Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA (2009) Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131: 2072–2073. doi:10.1021/ja808719p
Chiu YL, Rana TM (2003) siRNA function in RNAi: a chemical modification analysis. RNA 9: 1034–1048. doi:10.1261/rna.5103703
Parrish S, Fleenor J, Xu SQ, Mello C, Fire A (2000) Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell 6: 1077–1087. doi:10.1016/S1097-2765(00)00106-4
Sipa K, Sochacka E, Kazmierczak-Baranska J, Maszewska M, Janicka M, Nowak G, Nawrot B (2007) Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA. RNA 13: 1301–1316. doi:10.1261/rna.538907
Somoza A, Chelliserrykattil J, Kool ET (2006) The roles of hydrogen bonding and sterics in RNA interference. Angew Chem Int Edn 45: 4994–4997. doi:10.1002/anie.200601311
Xia J, Noronha A, Toudjarska I, Li F, Akinc A, Braich R, Frank-Kamenetsky M, Rajeev KG, Egli M, Manoharan M (2006) Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide. ACS Chem Biol 1: 176–183. doi:10.1021/cb600063p
Somoza A, Silverman AP, Miller RM, Chelliserrykattil J, Kool ET (2008) Steric Effects in RNA interference: probing the influence of nucleobase size and shape. Chem Eur J 14: 7978–7987. doi:10.1002/chem.200800837
Terrazas M, Kool ET (2009) RNA major groove modifications improve siRNA stability and biological activity. Nucleic Acids Res 37: 346–353. doi:10.1093/nar/gkn958
Bergstrom DE, Ruth JL (1976) Synthesis of C-5 substituted pyrimidine nucleosides via organopalladium intermediates. J Am Chem Soc 98: 1587–1589. doi:10.1021/ja00422a056
Bergstrom DE, Ogawa MK (1978) C-5 Substituted pyrimidine nucleosides. 2. Synthesis via olefin coupling to organopalladium intermediates derived from uridine and 2′-deoxyuridine. J Am Chem Soc 100: 8106–8112. doi:10.1021/ja00494a014
Shapira J (1962) Synthesis of 5-ethyluridine, a model 5-alkylsubstituted pyrimidine nucleoside. J Org Chem 27: 1918–1919. doi:10.1021/jo01052a528
Niedballa U, Vorbrüggen H (1974) Synthesis of nucleosides, 9, General synthesis of N-glycosides. I. Synthesis of pyrimidine nucleosides. J Org Chem 39: 3654–3660. doi:10.1021/jo00939a008
Herdewijn P, Kerremans L, Wigerinck P, Vandendriessche F, van Aerschot A (1991) Synthesis of thymidine from 5-iodo-2′-deoxyuridine. Tetrahedron Lett 32: 4397–4400. doi:10.1016/S0040-4039(00)92180-4
Hakimelahi GH, Proba ZA, Ogilvie KK (1982) New catalysts and procedures for the dimethoxytritylation and selective silylation of ribonucleosides. Can J Chem 60: 1106–1113. doi:10.1139/v82-165
Harborth J, Elbashir SM, Vandenburgh K, Manninga H, Scaringe SA, Weber K, Tuschl T (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic A 13: 83–105. doi:10.1089/108729003321629638
Hayakawa T, Ono A, Ueda T (1988) Synthesis of decadeoxyribonucleotides containing 5-modified uracils and their interactions with restriction endonucleases BglII, Sau3AI and MboI. Nucleic Acids Res 16: 4761–4776. doi:10.1093/nar/16.11.4761
Kypr J, Sági J, Szakonyi E, Ebinger K, Penazová H, Chládkova J, Vorlícková M (1994) Thymine methyl groups stabilize the putative A-form of the synthetic DNA poly(amino 2 dA-dT). Biochemistry-US 33: 3801–3806. doi:10.1021/bi00179a003
Marzabal S, DuBois S, Thielking V, Cano A, Eritja R, Guschlbauer W (1995) Dam methylase from Escherichia coli: kinetic studies using modified DNA oligomers: hemimethylated substrates. Nucleic Acids Res 23: 3648–3655. doi:10.1093/nar/23.18.3648
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
The Below is the Electronic Supplementary Material.
Rights and permissions
About this article
Cite this article
Terrazas, M., Eritja, R. Synthesis and properties of small interfering RNA duplexes carrying 5-ethyluridine residues. Mol Divers 15, 677–686 (2011). https://doi.org/10.1007/s11030-010-9290-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-010-9290-1